EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Sleep Apnea and Cardiac Structure and Function in Patients With Heart Failure with Preserved Ejection Fraction: Insights From the PARAGON-HF Trial

Sophia R Schneider, Henri Lu, Maja Cikes, Riccardo M Inciardi, Narayana Prasad, Bela Merkely, Annamaria Kosztin, Brian L Claggett, Amil M Shah, Mauro Gori, Muthiah Vaduganathan, Sheila M Hegde und 4 weitere

Journal of Cardiac Failure · 2026-07 · 32 (7) · 1176-1185

DOI: 10.1016/j.cardfail.2025.09.035 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cardiac Failure, 2026-07. Verfasst von Sophia R Schneider und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston MA, USA. Hauptthemen laut MEDLINE: Heart Failure, Stroke Volume, Sleep Apnea Syndromes, Ventricular Function, Left. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Novartis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sleep apnea is common in patients with heart failure with preserved ejection fraction (HFpEF). However, the impact of sleep apnea on cardiac structure, function, and outcomes is not well understood. We assessed clinical outcomes and echocardiographic characteristics in participants of the PARAGON-HF echocardiographic substudy. METHODS: PARAGON-HF was a randomized clinical trial of sacubitril/valsartan vs valsartan in patients with heart failure (HF) and left ventricular ejection fraction (LVEF) ≥45%. Echocardiographic variables were adjusted for clinically relevant parameters at baseline. The risk of total HF hospitalization (HFH) and cardiovascular (CV) death by sleep apnea status was analyzed using the semiparametric method of Lin, Wei, Yang, and Ying (LWYY). RESULTS: Among 1097 patients in the PARAGON-HF echocardiographic substudy, 133 (12.1%) had a reported history of sleep apnea. Those with sleep apnea were younger (72 vs 74 years), more often men (64% vs 45%), and had a higher body mass index (33 vs 29 kg/m2). They also had a higher prevalence of diabetes (53% vs 39%) and lower diastolic blood pressure. At baseline, those with sleep apnea had greater adjusted left ventricular (LV) mass index (93 vs 87 g/m²), worse absolute LV global longitudinal strain (15% vs 16%), and worse absolute right ventricular (RV) free wall longitudinal strain (17% vs 19%). Patients with sleep apnea experienced a higher risk of HFH and CV death than those without (adjusted risk ratio = 1.57, 95% CI 1.05, 2.35, P = 0.029), independent of LVEF (P = 0.92). CONCLUSIONS: Patients with HFpEF and sleep apnea exhibited evidence of LV remodeling, subclinical biventricular myocardial dysfunction, and an increased risk of adverse CV events compared to those without sleep apnea, regardless of LVEF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureStroke VolumeSleep Apnea SyndromesVentricular Function, LeftHeart VentriclesHumansMaleFemaleAgedEchocardiographyBiphenyl CompoundsValsartanDrug CombinationsAminobutyratesTetrazolesGlobal Longitudinal StrainMiddle AgedFollow-Up Studies

Stichwörter der Autor:innen

HFpEFSleep apneaechocardiography

Substanzen

Biphenyl CompoundsValsartanDrug CombinationsAminobutyratessacubitril and valsartan sodium hydrate drug combinationTetrazoles

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston MA, USA.
  • Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston MA, USA; Division of Cardiology, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne VD, Switzer…
  • Department of Cardiovascular Diseases, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
  • Institute of Cardiology, University of Brescia, Brescia, Italy.
  • Semmelweis University Heart and Vascular Center, Budapest, Hungary.
  • Division of Cardiovascular Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Förderung

  • Novartis

Zitieren

APA

Schneider, S. R., Lu, H., Cikes, M., Inciardi, R. M., Prasad, N., Merkely, B., Kosztin, A., Claggett, B. L., Shah, A. M., Gori, M., Vaduganathan, M., Hegde, S. M., McMurray, J. J. V., Solomon, S. D., Pabon, M. A., & Skali, H. (2026). Sleep Apnea and Cardiac Structure and Function in Patients With Heart Failure with Preserved Ejection Fraction: Insights From the PARAGON-HF Trial. Journal of Cardiac Failure, 32(7), 1176-1185. https://doi.org/10.1016/j.cardfail.2025.09.035

Vancouver

Schneider SR, Lu H, Cikes M, Inciardi RM, Prasad N, Merkely B, et al. Sleep Apnea and Cardiac Structure and Function in Patients With Heart Failure with Preserved Ejection Fraction: Insights From the PARAGON-HF Trial. Journal of Cardiac Failure. 2026;32(7):1176-1185. doi:10.1016/j.cardfail.2025.09.035

BibTeX
@article{Schneider2026,
  author = {Schneider, Sophia R and Lu, Henri and Cikes, Maja and Inciardi, Riccardo M and Prasad, Narayana and Merkely, Bela and Kosztin, Annamaria and Claggett, Brian L and Shah, Amil M and Gori, Mauro and Vaduganathan, Muthiah and Hegde, Sheila M and McMurray, John J V and Solomon, Scott D and Pabon, Maria A and Skali, Hicham},
  title = {Sleep Apnea and Cardiac Structure and Function in Patients With Heart Failure with Preserved Ejection Fraction: Insights From the PARAGON-HF Trial},
  journal = {Journal of Cardiac Failure},
  year = {2026},
  volume = {32},
  number = {7},
  pages = {1176--1185},
  doi = {10.1016/j.cardfail.2025.09.035}
}
Kostenlos starten →